Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial

Background: Patients with ischaemic stroke or transient ischaemic attack (TIA) are at high risk of recurrent stroke or other cardiovascular events. We compared the selective thromboxane-prostaglandin receptor antagonist terutroban with aspirin in the prevention of cerebral and cardiovascular ischaem...

Täydet tiedot

Bibliografiset tiedot
Päätekijät:	Bousser, M, Amarenco, P, Chamorro, A, Fisher, M, Ford, I, Fox, K, Hennerici, MG, Mattle, H, Rothwell, P, De Cordoüe, A, Fratacci, M
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2011

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Tekijä Bousser, MG, Amarenco, P, Chamorro, A, Fisher, M, Ford, I, Fox, K, Hennerici, MG, Mattle, H, Rothwell, P, de Cordoüe, A, Fratacci, MD

Julkaistu 2011

Journal article

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Tekijä Bousser, MG, Amarenco, P, Chamorro, A, Fisher, M, Ford, I, Fox, K, Hennerici, MG, Mattle, H, Rothwell, P, de Cordoüe, A, Fratacci, MD

Samankaltaisia teoksia